The overall increase in antidepressant dispensing in the UK is driven by longer treatment durations rather than increasing initiation rates, which have stabilized since 2001.
Answers are grounded in this paper and cite their sources.
Longer SSRI durations may drive UK antidepressant increases; leaves open optimal episode length and outcome effects in real-world cohorts.
BACKGROUND: Recent media reports have focused on the large increase in antidepressants dispensed in England. We investigated this, focusing on selective serotonin reuptake inhibitors (SSRIs). AIMS: To examine the rate of initiation of SSRIs over time and changes over time in the duration of prescribing episodes. METHOD: We estimated initiation and duration of SSRI prescribing from 7 025 802 individuals aged over 18 years and registered with a general practice that contributed data to The Health Improvement Network. RESULTS: Rates of SSRI initiation increased from 1.03 per 100 person-years in 1995 to 2.15 in 2001, but remained stable from then to 2012. The median duration of prescribing episodes increased from 112 to 169 days for episodes starting in 1995 to 2010. CONCLUSIONS: Despite media reports describing an increasing rate of antidepressant prescribing, SSRI initiation rates have stabilised since 2001. However, our results suggest that individuals who take SSRIs are receiving treatment for longer.
No takes yet. Share an insight, caveat, or question.
McCrea et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: